Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring
Wen Li et al.
MOLECULAR CANCER (2022)
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
D. Gale et al.
ANNALS OF ONCOLOGY (2022)
Liquid biopsy: current technology and clinical applications
Mina Nikanjam et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Progress on pivotal role and application of exosome in lung cancer carcinogenesis, diagnosis, therapy and prognosis
Ming-Yue Li et al.
MOLECULAR CANCER (2021)
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
Bin Qiu et al.
NATURE COMMUNICATIONS (2021)
Liquid Biopsy-Based Biosensors for MRD Detection and Treatment Monitoring in Non-Small Cell Lung Cancer (NSCLC)
Parvaneh Sardarabadi et al.
BIOSENSORS-BASEL (2021)
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review
Stepan M. Esagian et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
PyClone-VI: scalable inference of clonal population structures using whole genome data
Sierra Gillis et al.
BMC BIOINFORMATICS (2020)
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Scott V. Bratman et al.
NATURE CANCER (2020)
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Gabriele De Rubis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Detection of Solid Tumor Molecular Residual Disease(MRD) Using Circulating Tumor DNA (ctDNA)
Re-I Chin et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
MFEprimer-3.0: quality control for PCR primers
Kun Wang et al.
NUCLEIC ACIDS RESEARCH (2019)
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Bradon R. McDonald et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
fastp: an ultra-fast all-in-one FASTQ preprocessor
Shifu Chen et al.
BIOINFORMATICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid
Sojung Park et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
Navya Nair et al.
PLOS MEDICINE (2016)
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
Leticia De Mattos-Arruda et al.
NATURE COMMUNICATIONS (2015)
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers
Jian Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature
Kitty Huang et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
J-J Hung et al.
THORAX (2009)
Share Paper
